HK1201213A1 - Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture - Google Patents

Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture Download PDF

Info

Publication number
HK1201213A1
HK1201213A1 HK15101786.9A HK15101786A HK1201213A1 HK 1201213 A1 HK1201213 A1 HK 1201213A1 HK 15101786 A HK15101786 A HK 15101786A HK 1201213 A1 HK1201213 A1 HK 1201213A1
Authority
HK
Hong Kong
Prior art keywords
composition
bone
manufacture
methods
biocompatible
Prior art date
Application number
HK15101786.9A
Other languages
English (en)
Chinese (zh)
Inventor
Katarzyna I. GORNA
Andreas Goessl
Heinz Gulle
Original Assignee
Baxter International Inc
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc, Baxter Healthcare Sa filed Critical Baxter International Inc
Publication of HK1201213A1 publication Critical patent/HK1201213A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L73/00—Compositions of macromolecular compounds obtained by reactions forming a linkage containing oxygen or oxygen and carbon in the main chain, not provided for in groups C08L59/00 - C08L71/00; Compositions of derivatives of such polymers
    • C08L73/02—Polyanhydrides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00831—Material properties
    • A61B2017/00933—Material properties bone or bone-like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
    • C08G2650/58—Ethylene oxide or propylene oxide copolymers, e.g. pluronics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15101786.9A 2011-10-28 2012-10-29 Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture HK1201213A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161553032P 2011-10-28 2011-10-28
US201161553032P 2011-10-28
PCT/US2012/062437 WO2013063580A1 (en) 2011-10-28 2012-10-29 Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture

Publications (1)

Publication Number Publication Date
HK1201213A1 true HK1201213A1 (en) 2015-08-28

Family

ID=48168649

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15101786.9A HK1201213A1 (en) 2011-10-28 2012-10-29 Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture

Country Status (12)

Country Link
US (2) US9512277B2 (https=)
EP (2) EP2771040B1 (https=)
JP (1) JP6095675B2 (https=)
KR (2) KR102068118B1 (https=)
CN (1) CN104010669A (https=)
AU (1) AU2012328415B2 (https=)
BR (1) BR112014010192B1 (https=)
CA (2) CA2853732C (https=)
ES (2) ES2961982T3 (https=)
HK (1) HK1201213A1 (https=)
MX (1) MX359402B (https=)
WO (2) WO2013063580A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101712809B1 (ko) * 2015-03-19 2017-03-08 주식회사 엠아이텍 뼈 지혈용 생체 흡수성 조성물 및 이의 제조 방법
CN105816905B (zh) * 2016-04-15 2020-12-18 广州贝奥吉因生物科技有限公司 一种具有促愈合功能的可吸收骨蜡及其制备方法
CN106039390A (zh) * 2016-05-27 2016-10-26 中国人民解放军第七五医院 一种骨蜡组合物及其制备方法
KR101990069B1 (ko) * 2017-11-28 2019-06-18 ㈜솔시온바이오메디칼 뼈 지혈용품 조성물
CN109125791B (zh) * 2018-09-29 2019-08-30 广州贝奥吉因生物科技有限公司 一种具有促进骨修复功能的可吸收骨蜡及制备方法
KR102220832B1 (ko) 2018-12-13 2021-02-25 건양대학교 산학협력단 세포 독성이 감소된 생체흡수성 뼈 지혈제의 제조방법
KR102211765B1 (ko) * 2019-01-15 2021-02-03 주식회사 테라시온바이오메디칼 흡수성 골 지혈재 조성물 및 이를 이용한 골 지혈재 제조방법
CN111714684A (zh) * 2019-03-19 2020-09-29 广东博与再生医学有限公司 一种骨止血材料及其制备方法
KR102133503B1 (ko) * 2019-08-19 2020-07-13 한스바이오메드 주식회사 골지혈제용 생체 적합성 조성물, 이를 사용하는 치료 방법, 및 이의 제조 방법
US12285546B2 (en) 2019-08-27 2025-04-29 Dof Inc. Animal fat-derived extracellular matrix, and preservation solution of animal fat-derived extracellular matrix
CN114404642A (zh) * 2022-04-01 2022-04-29 天新福（北京）医疗器材股份有限公司 一种可吸收止血骨泥及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3171072D1 (en) * 1981-06-25 1985-07-25 Stroetmann M Serapharm Enriched plasma derivative for promoting wound sealing and wound covering
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
USRE38558E1 (en) 1991-03-19 2004-07-20 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
AU6898996A (en) * 1995-08-21 1997-03-12 Cytrx Corporation Compositions and methods for growth promotion
US6194515B1 (en) * 1997-10-10 2001-02-27 E. I. Du Pont De Nemours And Company Polyacetal composition with improved toughness
US9616150B2 (en) * 1999-10-29 2017-04-11 Children's Hospital Los Angeles Bone hemostasis method and materials
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
WO2003072157A1 (en) * 2002-02-21 2003-09-04 Encelle, Inc. Immobilized bioactive hydrogel matrices as surface coatings
DE10225420A1 (de) * 2002-06-07 2003-12-24 Sanatis Gmbh Strontium-Apatit-Zement-Zubereitungen, die daraus gebildeten Zemente und die Verwendung davon
US20060258560A1 (en) * 2002-09-30 2006-11-16 Chunlin Yang Dry tissue sealant compositions
JP5508661B2 (ja) 2003-02-12 2014-06-04 シンセラ インコーポレイテッド ランダムおよび非ランダムアルキレンオキシドポリマーアロイ組成物
EP1684819A2 (en) * 2003-11-20 2006-08-02 Angiotech International Ag Polymer compositions and methods for their use
CA2571656A1 (en) 2004-06-23 2006-01-05 Angiotech Biomaterials Corporation Methods and crosslinked polymer compositions for cartilage repair
US8603528B2 (en) * 2004-09-16 2013-12-10 Abyrx, Inc. Compositions and method for the reduction of post-operative pain
NZ563557A (en) * 2005-07-25 2011-04-29 Orthocon Inc Compositions and methods for the reduction of post-operative pain
CA2646486A1 (en) * 2006-03-23 2007-09-27 Citagenix Inc. Reverse phase osteoconductive composition
EP2026756B1 (en) 2006-05-22 2020-06-17 Syncera, Inc. Resorbable polymer compositions for use in medicine, dentistry, and surgery
US8309521B2 (en) * 2007-06-19 2012-11-13 Zimmer, Inc. Spacer with a coating thereon for use with an implant device
US8815973B2 (en) * 2007-08-28 2014-08-26 Pioneer Surgical Technology, Inc. Cement products and methods of making and using the same
EP2227212A1 (en) * 2007-12-07 2010-09-15 BioCure, Inc. Bone substitute
GB0801935D0 (en) * 2008-02-01 2008-03-12 Apatech Ltd Porous biomaterial
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
US20100233269A1 (en) * 2009-03-13 2010-09-16 Baxter International, Inc. Mineralized polymer particles and the method for their production
BRPI1014139A2 (pt) * 2009-06-29 2016-04-26 Bender Analytical Holding Bv sistema de liberação de fármacos compreendendo polioxazolina e um agente biotivo.
AU2011239742B2 (en) 2010-04-16 2014-11-27 Apatech Limited Biomaterial
WO2014086996A1 (en) * 2012-12-07 2014-06-12 Baxter International Inc. Hemostatic foam

Also Published As

Publication number Publication date
KR102184970B1 (ko) 2020-12-03
CN104010669A (zh) 2014-08-27
EP3878483B1 (en) 2023-08-09
EP3878483A1 (en) 2021-09-15
EP2771040A4 (en) 2015-05-27
WO2013063580A1 (en) 2013-05-02
US9512277B2 (en) 2016-12-06
KR102068118B1 (ko) 2020-01-20
ES2877715T3 (es) 2021-11-17
EP2771040A1 (en) 2014-09-03
EP2771040B1 (en) 2021-05-26
BR112014010192A2 (pt) 2017-04-18
US20130287818A1 (en) 2013-10-31
MX2014005135A (es) 2014-10-06
WO2013063585A1 (en) 2013-05-02
CA2853732C (en) 2021-06-08
AU2012328415B2 (en) 2016-03-17
US20130177601A1 (en) 2013-07-11
MX359402B (es) 2018-09-26
CA2853732A1 (en) 2013-05-02
AU2012328415A1 (en) 2014-05-15
ES2961982T3 (es) 2024-03-14
KR20140084265A (ko) 2014-07-04
KR20200010567A (ko) 2020-01-30
CA3107935A1 (en) 2013-05-02
JP2014532481A (ja) 2014-12-08
BR112014010192B1 (pt) 2019-05-14
JP6095675B2 (ja) 2017-03-15

Similar Documents

Publication Publication Date Title
HK1201213A1 (en) Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture
WO2013060769A3 (en) Hemostatic compositions
WO2012122044A3 (en) Flowable collagen-based hemostat and methods of use
HK1201212A1 (en) Hemostatic compositions
WO2009155594A3 (en) Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator
EA201390600A1 (ru) Терапевтические наночастицы с сополимерами с большим молекулярным весом
EA201170039A1 (ru) Полимерные частицы, нагруженные лекарственным средством, и способы их получения и применения
WO2011110894A3 (en) A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition
MX2014004477A (es) Composiciones hemostaticas.
WO2010033977A3 (en) Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
WO2011005937A3 (en) Mono ethylenically unsaturated polymerizable group containing polycarbosiloxane monomers
HK1200023A1 (en) Absorbable multi-putty bone cements and hemostatic compositions and methods of use
AU2018256550A1 (en) Compositions comprising crossed linked cation-binding polymers
EP4371615A3 (en) Treatment of amd using aav sflt-1
BRPI0923362B8 (pt) método de produção de uma composição de liberação controlada de fosfato de ácido ascórbico, composição de liberação controlada e dispositivo médico.
WO2012016186A8 (en) Macrocyclic kinase inhibitors and uses thereof
PH12014500192A1 (en) Biodegradable, semi-crystalline, phase separated, thermoplastic multi block copolymers for controlled release of biologically active compounds
BR112014010542A2 (pt) métodos e composições para tratamento de ferimento
WO2009139576A3 (ko) 신규 벤즈옥사졸로 치환된 피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 이상세포 성장 질환의 예방 및 치료용 약학적 조성물
WO2013061309A3 (en) New a-prp medical device & tissue engineering composition, manufacturing machines and process
WO2012009715A3 (en) Novel cyclosporin derivatives for the treatment and prevention of a viral infection
HK1201469A1 (en) Compositions and methods for hemostasis
GEP20166488B (en) Co-crystals and salts of ccr3-inhibitors
WO2011126839A3 (en) Compositions and methods for improved retention of a pharmaceutical composition at a local administration site
EP4279128A3 (en) Novel antibody binding to tfpi and composition comprising the same